BrightSpring Health Services (NASDAQ:BTSG) Research Coverage Started at BTIG Research

BTIG Research started coverage on shares of BrightSpring Health Services (NASDAQ:BTSG – Free Report) in a report published on Friday, Marketbeat.com reports. The firm issued a buy rating and a $15.00 price objective on the stock.

Several other equities research analysts have also recently weighed in on the stock. The Goldman Sachs Group cut their price objective on shares of BrightSpring Health Services from $26.00 to $23.00 and set a buy rating for the company in a research report on Monday, March 4th. Wells Fargo & Company upped their price objective on shares of BrightSpring Health Services from $15.00 to $16.00 and gave the stock an overweight rating in a research report on Monday, May 6th. Deutsche Bank Aktiengesellschaft raised shares of BrightSpring Health Services from a hold rating to a buy rating and set a $11.50 target price for the company in a report on Tuesday, February 27th. Finally, HSBC began coverage on shares of BrightSpring Health Services in a report on Wednesday, March 6th. They issued a buy rating and a $13.00 target price for the company. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of Buy and a consensus price target of $15.77.

Get Our Latest Analysis on BrightSpring Health Services

BrightSpring Health Services Trading Up 1.9 %

Shares of BTSG stock traded up $0.20 on Friday, hitting $10.62. The company’s stock had a trading volume of 934,499 shares, compared to its average volume of 1,715,859. BrightSpring Health Services has a fifty-two week low of $7.85 and a fifty-two week high of $12.21. The business has a 50 day simple moving average of $11.01. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.96 and a current ratio of 1.26.

BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.06. The firm had revenue of $2.58 billion for the quarter, compared to the consensus estimate of $2.31 billion. During the same period in the prior year, the company earned ($0.10) EPS. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in BTSG. Kohlberg Kravis Roberts & Co. L.P. bought a new position in BrightSpring Health Services in the 1st quarter valued at approximately $884,166,000. 8 Knots Management LLC acquired a new stake in BrightSpring Health Services in the 1st quarter valued at $67,678,000. Vanguard Group Inc. acquired a new stake in BrightSpring Health Services in the 1st quarter valued at $54,638,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in BrightSpring Health Services in the 1st quarter valued at $35,328,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in BrightSpring Health Services in the 1st quarter valued at $16,260,000.

About BrightSpring Health Services

(Get Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company’s platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Should you invest $1,000 in BrightSpring Health Services right now?

Before you consider BrightSpring Health Services, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and BrightSpring Health Services wasn’t on the list.

While BrightSpring Health Services currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we’ll send you MarketBeat’s guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report